Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Dollarama Stock (TSX: DOL) Near Fresh Highs on Dec. 24, 2025: Earnings Momentum, Global Expansion, and a Valuation Test

Dollarama Stock (TSX: DOL) Near Fresh Highs on Dec. 24, 2025: Earnings Momentum, Global Expansion, and a Valuation Test

Dollarama is ending 2025 in the spotlight as investors weigh a familiar question with an unusually sharp edge: how much is too much to pay for a business that keeps delivering? On December 24, 2025, the discussion is unfolding against a holiday-thinned trading session in Canada—markets are scheduled to close early—after the S&P/TSX set new records and heads toward its best annual performance since 2009. Reuters
24 December 2025
··
Reviva Pharmaceuticals (RVPH) Stock Plunges After FDA Calls for Second Phase 3 Trial: News, Forecasts, and Analyst Takeaways on Dec. 24, 2025

Reviva Pharmaceuticals (RVPH) Stock Plunges After FDA Calls for Second Phase 3 Trial: News, Forecasts, and Analyst Takeaways on Dec. 24, 2025

Reviva Pharmaceuticals Holdings, Inc. is in the spotlight on December 24, 2025 after a sharp selloff driven by a major regulatory development: the U.S. Food and Drug Administration recommended that Reviva run an additional Phase 3 trial for its lead schizophrenia candidate, brilaroxazine, before filing a New Drug Application. SEC+1
24 December 2025
···
Stock Market Today: U.S. Futures Dip on Christmas Eve as S&P 500 Holds Record High and GDP Surprise Trims Rate‑Cut Bets

Stock Market Today: U.S. Futures Dip on Christmas Eve as S&P 500 Holds Record High and GDP Surprise Trims Rate‑Cut Bets

Wall Street is heading into Christmas Eve trading with a familiar holiday mix: thin liquidity, an early close, and outsized market attention on macro headlines after the S&P 500 finished Tuesday at a fresh record. U.S. stock index futures were modestly lower in premarket action, as traders weighed an unexpectedly strong U.S. growth reading against stubborn inflation signals that are complicating the path for Federal Reserve rate cuts in 2026. Reuters+2Reuters+2
24 December 2025
Indaptus Therapeutics (INDP) Stock in Focus on Dec. 24, 2025: $6M Financing, Leadership Reset, and the Dilution Question

Indaptus Therapeutics (INDP) Stock in Focus on Dec. 24, 2025: $6M Financing, Leadership Reset, and the Dilution Question

Indaptus Therapeutics, Inc. is getting unusual attention heading into December 24, 2025, after a late-December SEC filing laid out a $6.0 million preferred-stock financing, a boardroom reshuffle, and a new co-CEO / chairman appointment—a mix that can ignite short-term trading interest while also forcing investors to re-run the long-term share-count math. SEC+1
24 December 2025
··
NVIDIA Stock News Today (Dec 24, 2025): NVDA Eyes China H200 Shipments as Wall Street Lifts 2026 Forecasts

NVIDIA Stock News Today (Dec 24, 2025): NVDA Eyes China H200 Shipments as Wall Street Lifts 2026 Forecasts

NVIDIA Corporation is heading into Christmas Eve with a familiar mix of fuel and friction: a powerful AI demand narrative, a fresh policy twist on China chip exports, and the kind of valuation debate that never sleeps—even when the market calendar tries to. NVDA last traded around $189.21, keeping the stock near the center of the “Magnificent Seven” conversation as investors position for 2026. StockAnalysis+1
24 December 2025
··
Sable Offshore Corp (SOC) Stock News Today: PHMSA Clears Las Flores Pipeline Restart — Latest Price, Forecasts, and What Comes Next (Dec. 24, 2025)

Sable Offshore Corp (SOC) Stock News Today: PHMSA Clears Las Flores Pipeline Restart — Latest Price, Forecasts, and What Comes Next (Dec. 24, 2025)

Sable Offshore Corp. is back in the spotlight on December 24, 2025, after a key federal regulatory decision reignited investor optimism about the company’s ability to restart a long-idled California pipeline system—an outcome that matters because Sable’s business is heavily concentrated in a single offshore project.
24 December 2025
··
Dynavax Technologies (DVAX) Stock Jumps on Sanofi’s $2.2B Cash Buyout Offer: Latest News, Forecasts, and What Comes Next (Dec. 24, 2025)

Dynavax Technologies (DVAX) Stock Jumps on Sanofi’s $2.2B Cash Buyout Offer: Latest News, Forecasts, and What Comes Next (Dec. 24, 2025)

Dynavax Technologies Corporation is the center of the biotech tape on Wednesday, December 24, 2025, after Sanofi announced a deal to acquire the vaccine maker in an all-cash transaction valued at roughly $2.2 billion. The headline number investors are keying on: $15.50 per share in cash—a bid that reframes the near-term outlook for DVAX stock from “earnings and pipeline execution” to “deal timeline and closing risk.” Sanofi+1
24 December 2025
···
BP Stock Jumps on $6 Billion Castrol Stake Sale: What It Means for BP Shares, Debt, Dividends, and 2026 Outlook (Dec. 24, 2025)

BP Stock Jumps on $6 Billion Castrol Stake Sale: What It Means for BP Shares, Debt, Dividends, and 2026 Outlook (Dec. 24, 2025)

London/New York — December 24, 2025 — BP p.l.c. is back in the spotlight on Christmas Eve after agreeing to sell a controlling 65% stake in its Castrol lubricants business to U.S. investment firm Stonepeak, a deal BP says values Castrol at $10.1 billion and will deliver roughly $6 billion of net proceeds to the oil major. The market’s initial reaction was positive-but-measured: BP shares rose more than 1% shortly after the announcement before trading turned choppy in thin, holiday-shortened conditions. Reuters+1
24 December 2025
···
International Flag-State Association seeks IMO consultative status

International Flag-State Association seeks IMO consultative status

The world’s three largest ship registries—Liberia, the Republic of the Marshall Islands, and the Republic of Panama—are moving to elevate their joint platform, the International Flag-State Association, by preparing an application for consultative status at the International Maritime Organization. The step, first reported in trade coverage published between December 19 and December 23, is being framed by the registries as a shift from information-sharing toward a more direct role in shaping global maritime policymaking. ship.energy+3SAFETY4SEA+3Container News+3
24 December 2025
Moderna Stock (MRNA) Today: Shares Cool Off After a Late-December Spike as Investors Focus on Bird Flu Funding, mNEXSPIKE’s EU Path, and 2026 Growth Targets

Moderna Stock (MRNA) Today: Shares Cool Off After a Late-December Spike as Investors Focus on Bird Flu Funding, mNEXSPIKE’s EU Path, and 2026 Growth Targets

December 24, 2025 — Moderna, Inc. is ending 2025 with the kind of chart action that makes both traders and long-term biotech investors sit up straight. After a sharp multi-day run, Moderna stock pulled back hard: shares closed at about $32.29 on Dec. 23, down ~7.48% on the day, and were indicated around $32.11 in pre-market trading on Dec. 24. StockAnalysis
24 December 2025
··
1 … 407 408 409 410 411 … 609
Follow on Google News
Add as preferred source Open in Google News
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Xylem

NYSE: XYL 95 / 100
#2 BUY

AerCap

NYSE: AER 93 / 100
#3 BUY ON WEAKNESS

Visa

NYSE: V 90 / 100
#4 TACTICAL BUY

Chevron

NYSE: CVX 87 / 100
#5 ACCUMULATE

UPS

NYSE: UPS 84 / 100
View full portfolio
Editorial model selection. Not personalised advice.